| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Vergleich | Insidertrades | Knock-outs | myHome |
| Orderbuch | Realtime Stuttgart | RSS Feed | Analyse | im Forum | Fonds | Senden |
| Historisch | Realtime Push | myNews neu | IR-Daten | Anleihen | handeln | |
| Analyst | Buy | Hold | Sell | Kursziel* | Abstand | Datum |
|---|---|---|---|---|---|---|
| RBC Capital Markets | 15,00$ | - | 07.05.12 | |||
| Commerzbank Corp. & Markets | - | - | 04.05.12 | |||
| HSBC | 13,00€ | -1,74% | 03.05.12 | |||
| WestLB AG | 14,00€ | +5,82% | 02.05.12 | |||
| Barclays Capital | 17,00$ | - | 30.04.12 | |||
| Hamburger Sparkasse AG (Haspa) | - | - | 30.04.12 | |||
| Der Aktionärsbrief | - | - | 27.04.12 | |||
| Cheuvreux SA | 11,70€ | -11,56% | 26.04.12 | |||
| Exane-BNP Paribas SA | 1,70£ | - | 26.04.12 | |||
| UBS AG | 12,50€ | -5,52% | 26.04.12 | |||
| Independent Research GmbH | 13,00€ | -1,74% | 03.02.12 | |||
| Deutsche Bank AG | 21,00$ | - | 31.01.12 | |||
| Banc of America Securities-Merrill Lynch | 15,00€ | +13,38% | 06.01.12 | |||
| JP Morgan Chase & Co. | 19,00$ | - | 04.01.12 | |||
| Société Générale Group S.A. (SG) | 15,00€ | +13,38% | 01.12.11 | |||
| Euro am Sonntag | - | - | 10.10.11 | |||
| Macquarie Research | 13,80€ | +4,31% | 18.08.11 |
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Agennix AG | 0 | 1 | 0 | 2,00 € | +25,00% |
| Amgen Inc. | 5 | 10 | 1 | 72,09 $ | +4,06% |
| BB Biotech AG | 5 | 0 | 1 | 70,67 € | +6,43% |
| Biogen Idec Inc. | 9 | 2 | 0 | 139,20 $ | +5,82% |
| Biotest AG | 0 | 0 | 0 | - | - |
| Evotec AG | 3 | 0 | 0 | 3,75 € | +87,50% |
| Life Technologies Corp. | 0 | 0 | 0 | - | - |
| MorphoSys AG | 3 | 3 | 0 | 22,98 € | +34,46% |
| QIAGEN N.V. | 8 | 7 | 2 | 13,50 € | +2,04% |
| Roche Holding AG (Inhaberaktie) | 10 | 5 | 0 | 168,73 | +5,46% |
| Sigma-Aldrich Corp. | 0 | 0 | 0 | - | - |